MVP and prostate cancer: ARCaPM showed high levels of major vault protein (MVP or LRP) (P = 0.002, 1.41 log2 fold-change), a protein that is increased in advanced prostate cancer and expressed in drug resistant cell lines and various types of cancers [19, 20].